Page last updated: 2024-09-04

pomalidomide and Amyloidosis

pomalidomide has been researched along with Amyloidosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajek, R; Jelinek, T; Kufova, Z1
Lo, S; Sanchorawala, V; Seldin, DC; Shelton, AC; Sloan, JM; Varga, C1
Basset, M; Foli, A; Merlini, G; Milani, P; Palladini, G; Perlini, S; Russo, F1
Buadi, F; Detweiler-Short, K; Dingli, D; Dispenzieri, A; Gertz, MA; Hayman, S; Kumar, SK; Kyle, RA; Lacy, MQ; Leung, N; Lust, JA; Rajkumar, SV; Russell, SJ; Zeldenrust, S1
Bergsagel, PL; Buadi, F; Dingli, D; Dispenzieri, A; Fonseca, R; Gertz, MA; Hall, R; Hayman, SR; Kumar, SK; Lacy, MQ; LaPlant, B; Laumann, K; Lust, JA; Mikhael, JR; Rajkumar, SV; Reeder, C; Roy, V; Russell, SJ; Stewart, AK; Witzig, TE; Zeldenrust, SR1

Reviews

1 review(s) available for pomalidomide and Amyloidosis

ArticleYear
Immunomodulatory drugs in AL amyloidosis.
    Critical reviews in oncology/hematology, 2016, Volume: 99

    Topics: Amyloidosis; Animals; Humans; Immunoglobulin Light Chains; Immunologic Factors; Lenalidomide; Salvage Therapy; Thalidomide

2016

Trials

3 trial(s) available for pomalidomide and Amyloidosis

ArticleYear
Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial.
    Blood, 2016, 08-25, Volume: 128, Issue:8

    Topics: Adult; Aged; Amyloidosis; Dexamethasone; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Survival Analysis; Thalidomide; Treatment Outcome

2016
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis.
    Blood, 2017, 04-13, Volume: 129, Issue:15

    Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Bortezomib; Dexamethasone; Disease-Free Survival; Female; Humans; Immunoglobulin Light Chains; Immunologic Factors; Male; Middle Aged; Survival Rate; Thalidomide

2017
Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis.
    Blood, 2012, Jun-07, Volume: 119, Issue:23

    Topics: Aged; Aged, 80 and over; Amyloidosis; Antineoplastic Agents; Dexamethasone; Disease-Free Survival; Drug Therapy, Combination; Female; Hematologic Tests; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Plasma Cells; Thalidomide

2012

Other Studies

1 other study(ies) available for pomalidomide and Amyloidosis

ArticleYear
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs.
    American journal of hematology, 2010, Volume: 85, Issue:10

    Topics: Amyloid; Amyloidosis; Biomarkers; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Heart Failure; Humans; Immunoglobulin Light Chains; Immunologic Factors; Lenalidomide; Melphalan; Natriuretic Peptide, Brain; Patient Dropouts; Peptide Fragments; Stem Cell Transplantation; Thalidomide; Troponin T

2010